Cairo Oil & Soap Company (EGX:COSG)
Egypt · Delayed Price · Currency is EGP 0.3590
-0.0040 (-1.10%)
At close: Aug 5, 2025
CTI BioPharma Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 5.04 | 75.7 | 26.39 | 17.98 | 0.1 | 0.05 | Upgrade |
Cash & Short-Term Investments | 5.04 | 75.7 | 26.39 | 17.98 | 0.1 | 0.05 | Upgrade |
Cash Growth | -90.84% | 186.91% | 46.73% | 18177.88% | 82.94% | -84.44% | Upgrade |
Accounts Receivable | 285.36 | 221.87 | 79.72 | 21.98 | 2.55 | 1.54 | Upgrade |
Other Receivables | 1.74 | 1.82 | 9.72 | 6.55 | 7.25 | 8.14 | Upgrade |
Receivables | 287.1 | 223.69 | 89.44 | 28.54 | 9.79 | 9.67 | Upgrade |
Inventory | 158.16 | 98.1 | 91.58 | 37.18 | 6.22 | 16.95 | Upgrade |
Other Current Assets | 34.97 | 44.2 | 22.32 | 50.36 | 8.01 | 10.99 | Upgrade |
Total Current Assets | 485.28 | 441.69 | 229.72 | 134.05 | 24.12 | 37.67 | Upgrade |
Property, Plant & Equipment | 455.76 | 455.35 | 453.21 | 46.1 | 70.2 | 121.09 | Upgrade |
Total Assets | 941.04 | 897.04 | 682.93 | 180.15 | 94.32 | 158.76 | Upgrade |
Accounts Payable | 5.4 | 10.25 | 8.44 | 2.58 | 0.74 | 1.43 | Upgrade |
Accrued Expenses | 12.19 | 3.22 | 6.68 | 3.36 | 26.4 | 21.09 | Upgrade |
Short-Term Debt | 280.27 | 213.93 | 138.24 | 82.18 | 32.37 | 1.53 | Upgrade |
Current Portion of Leases | 21.62 | 27.73 | 21.31 | 17.37 | 78.53 | 23.48 | Upgrade |
Current Income Taxes Payable | - | 1.26 | 11.71 | 14.15 | 7.51 | 2.66 | Upgrade |
Current Unearned Revenue | - | - | 19.2 | - | - | - | Upgrade |
Other Current Liabilities | 35.33 | 44.91 | 66.51 | 25.51 | 76.38 | 74.66 | Upgrade |
Total Current Liabilities | 354.81 | 301.31 | 272.1 | 145.14 | 221.93 | 124.86 | Upgrade |
Long-Term Leases | 8.47 | 8.47 | 35.28 | 56.18 | 72.87 | 104.18 | Upgrade |
Long-Term Deferred Tax Liabilities | 51.46 | 52.61 | 52.66 | 5.43 | 4.87 | 3.98 | Upgrade |
Other Long-Term Liabilities | - | - | - | 39.34 | - | - | Upgrade |
Total Liabilities | 414.74 | 362.39 | 360.04 | 246.09 | 299.68 | 233.02 | Upgrade |
Common Stock | 312 | 312 | 234 | 234 | 39 | 195 | Upgrade |
Retained Earnings | -131.35 | -124.36 | -263.54 | -299.94 | -244.35 | -269.26 | Upgrade |
Comprehensive Income & Other | 345.65 | 347 | 352.43 | - | - | - | Upgrade |
Shareholders' Equity | 526.3 | 534.64 | 322.89 | -65.94 | -205.35 | -74.26 | Upgrade |
Total Liabilities & Equity | 941.04 | 897.04 | 682.93 | 180.15 | 94.32 | 158.76 | Upgrade |
Total Debt | 310.36 | 250.13 | 194.83 | 155.73 | 183.78 | 129.19 | Upgrade |
Net Cash (Debt) | -305.32 | -174.42 | -168.44 | -137.74 | -183.68 | -129.14 | Upgrade |
Net Cash Per Share | -0.09 | -0.06 | -0.07 | -0.06 | -0.47 | -0.33 | Upgrade |
Filing Date Shares Outstanding | 3,120 | 3,120 | 2,340 | 2,340 | 390 | 390 | Upgrade |
Total Common Shares Outstanding | 3,120 | 3,120 | 2,340 | 2,340 | 390 | 390 | Upgrade |
Working Capital | 130.47 | 140.38 | -42.38 | -11.09 | -197.81 | -87.18 | Upgrade |
Book Value Per Share | 0.17 | 0.17 | 0.14 | -0.03 | -0.53 | -0.19 | Upgrade |
Tangible Book Value | 526.3 | 534.64 | 322.89 | -65.94 | -205.35 | -74.26 | Upgrade |
Tangible Book Value Per Share | 0.17 | 0.17 | 0.14 | -0.03 | -0.53 | -0.19 | Upgrade |
Land | 195.47 | 195.47 | 195.47 | 2.55 | 2.55 | - | Upgrade |
Buildings | 73.82 | 73.92 | 67.64 | 16.64 | 23.26 | 7.68 | Upgrade |
Machinery | 223.32 | 223.12 | 213.38 | 72.08 | 116.58 | 116.95 | Upgrade |
Construction In Progress | 3.69 | 1.13 | 4.65 | 4.61 | 0.45 | - | Upgrade |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.